Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who are male and aged 18 or older, with no upper age limit
- People who have been diagnosed with prostate cancer confirmed through a tissue sample (biopsy)
- People who need imaging scans to check for signs of cancer spread, either at the time of first diagnosis or after cancer has returned or progressed following earlier treatment
- People who agree to take part and sign a written consent form
Who may not be able to join:
- People who are already taking part in another study that uses a type of advanced imaging (called Next-Generation Imaging) to check for cancer spread
- People who have another significant health condition that, in the opinion of the doctor running the trial, makes participation unsuitable (confirm with trial site)
- People who are unlikely to be able to complete the full study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Francesco Sanguedolce, MD, PhD, Fundació Puigvert
Phone: +34934169100
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of patients requiring NGI, conventional imaging, or a combination of both imaging tools.; Proportion of patients with a change of treatment determined by the imaging test result, when multiple imaging tests have been realized
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.